Skip to main content
×
Home
    • Aa
    • Aa

Characterization of hepatitis C infection in tuberculosis patients in an urban city in the USA

  • M. CAMPO (a1), A. SHRESTHA (a2), E. OREN (a2) (a3), H. THIEDE (a2) (a3), J. DUCHIN (a2) (a3), M. NARITA (a1) (a2) (a3) and K. CROTHERS (a1)
  • DOI: http://dx.doi.org/10.1017/S0950268813002355
  • Published online: 25 September 2013
Abstract
SUMMARY

The impact of hepatitis C virus infection (HCI), the most common bloodborne virus infection in the USA, on outcome of active tuberculosis (TB) treatment is largely unknown. We aimed to describe characteristics of TB patients with hepatitis C virus infection (TB-HCI) in King County, Washington, including TB treatment duration and outcome. We reviewed 1510 records of patients treated for active TB at the Public Health – Seattle & King County Tuberculosis Control Program between 2000 and 2010, and identified 53 with HCI. Advanced age, being born in the USA, HIV infection, homelessness and injection drug use were independently associated with HCI in TB cases. Independent factors associated with increased treatment duration included HIV infection, excess alcohol use, extrapulmonary TB, and any drug-resistant TB disease. Our findings suggest that TB-HCI patients can be successfully treated for active TB without extending treatment duration.

Copyright
Corresponding author
*Author for correspondence: Dr M. Campo, Division of Pulmonary and Critical Care Medicine, University of Washington, 325 Ninth Avenue Box 13965, Seattle, WA, USA. (Email: mcampo@u.washington.edu).
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

2.Global burden of disease (GBD) for hepatitis C. Journal of Clinical Pharmacology 2004; 44: 2029.

3. GLArmstrong , The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Annals of Internal Medicine 2006; 144: 705714.

4. EChak , Hepatitis C virus infection in USA: an estimate of true prevalence. Liver International 2011; 31: 10901101.

7. JRUngo , Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus. American journal of Respiratory and Critical Care Medicine 1998; 157: 18711876.

8. YSKwon , Hepatitis C virus infection and hepatotoxicity during antituberculosis chemotherapy. Chest 2007; 131: 803808.

10.P Baghaei , Incidence, clinical and epidemiological risk factors, and outcome of drug-induced hepatitis due to antituberculous agents in new tuberculosis cases. American Journal of Therapeutics 2010; 17: 1722.

11.U Beijer , A Wolf , S Fazel . Prevalence of tuberculosis, hepatitis C virus, and HIV in homeless people: a systematic review and meta-analysis. Lancet Infectious Diseases 2012; 12: 859870.

12.JJ Saukkonen , An official ATS statement: hepatotoxicity of antituberculosis therapy. American Journal of Respiratory and Critical Care Medicine 2006; 174: 935952.

19.HB El-Serag , Association between hepatitis C infection and other infectious diseases: a case for targeted screening? American Journal of Gastroenterology 2003; 98: 167174.

20.G Friedland . Infectious disease comorbidities adversely affecting substance users with HIV: hepatitis C and tuberculosis. Journal of Acquired Immune Deficiency Syndrome 2010; 55 (Suppl. 1): S3742.

22. MHKuniholm , Risk factors and algorithms to identify hepatitis C, hepatitis B, and HIV among Georgian tuberculosis patients. International Journal of Infectious Diseases 2008; 12: 5156.

23.MA Pando , Human immunodeficiency virus and tuberculosis in Argentina: prevalence, genotypes and risk factors. Journal of Medical Microbiology 2008; 57: 190197.

24. NRReis , Hepatitis C virus infection in patients with tuberculosis in Central Brazil. International Journal of Tuberculosis and Lung Disease 2011; 15: 13971402.

25. CSirinak , Viral hepatitis and HIV-associated tuberculosis: risk factors and TB treatment outcomes in Thailand. BMC Public Health 2008; 8: 245.

27.K Mitruka , CA Winston , TR Navin . Predictors of failure in timely tuberculosis treatment completion, United States. International Journal of Tuberculosis and Lung Disease 2012; 16: 10751082.

28.E Sbrana , Co-morbidities associated with tuberculosis in an autopsy case series. Tuberculosis 2011; 91 (Suppl. 1): S3842.

30.CA Winston , K Mitruka . Treatment duration for patients with drug-resistant tuberculosis, United States. Emerging Infectious Diseases 2012; 18: 12011202.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords: